These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24588756)

  • 1. Accelerated intensity frailty model for recurrent events data.
    Liu B; Lu W; Zhang J
    Biometrics; 2014 Sep; 70(3):579-87. PubMed ID: 24588756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoothing spline ANOVA frailty model for recurrent event data.
    Du P; Jiang Y; Wang Y
    Biometrics; 2011 Dec; 67(4):1330-9. PubMed ID: 21457192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kernel Smoothed Profile Likelihood Estimation in the Accelerated Failure Time Frailty Model for Clustered Survival Data.
    Liu B; Lu W; Zhang J
    Biometrika; 2013; 100(3):741-755. PubMed ID: 24443587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spline-based semiparametric projected generalized estimating equation method for panel count data.
    Hua L; Zhang Y
    Biostatistics; 2012 Jul; 13(3):440-54. PubMed ID: 21926062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced smoothing for rank-based regression with recurrent gap time data.
    Lyu T; Luo X; Xu G; Huang CY
    Stat Med; 2018 Mar; 37(7):1086-1100. PubMed ID: 29205446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient estimation for accelerated failure time model under case-cohort and nested case-control sampling.
    Kang S; Lu W; Liu M
    Biometrics; 2017 Mar; 73(1):114-123. PubMed ID: 27479331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An accelerated failure time mixture cure model with masked event.
    Zhang JJ; Wang M
    Biom J; 2009 Dec; 51(6):932-45. PubMed ID: 20029894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A smoothing expectation and substitution algorithm for the semiparametric accelerated failure time frailty model.
    Johnson LM; Strawderman RL
    Stat Med; 2012 Sep; 31(21):2335-58. PubMed ID: 22437629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flexible semiparametric transformation model for recurrent event data.
    Dong L; Sun L
    Lifetime Data Anal; 2015 Jan; 21(1):20-41. PubMed ID: 24241908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric quasi-likelihood for right censored data.
    Yu L
    Lifetime Data Anal; 2011 Oct; 17(4):594-607. PubMed ID: 21800175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.
    Chen MH; Ibrahim JG; Zeng D; Hu K; Jia C
    Biometrics; 2014 Dec; 70(4):1003-13. PubMed ID: 25041037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An additive-multiplicative rates model for recurrent event data with informative terminal event.
    Sun L; Kang F
    Lifetime Data Anal; 2013 Jan; 19(1):117-37. PubMed ID: 22965680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiparametric estimation for nonparametric frailty models using nonparametric maximum likelihood approach.
    Chee CS; Do Ha I; Seo B; Lee Y
    Stat Methods Med Res; 2021 Nov; 30(11):2485-2502. PubMed ID: 34569366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum likelihood estimation of semiparametric mixture component models for competing risks data.
    Choi S; Huang X
    Biometrics; 2014 Sep; 70(3):588-98. PubMed ID: 24734912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic analysis of recurrent event data using the additive hazard model.
    Fosen J; Borgan O; Weedon-Fekjaer H; Aalen OO
    Biom J; 2006 Jun; 48(3):381-98. PubMed ID: 16845903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint frailty models for zero-inflated recurrent events in the presence of a terminal event.
    Liu L; Huang X; Yaroshinsky A; Cormier JN
    Biometrics; 2016 Mar; 72(1):204-14. PubMed ID: 26295794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive mixed effect model for clustered failure time data.
    Cai J; Zeng D
    Biometrics; 2011 Dec; 67(4):1340-51. PubMed ID: 21418052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the adequacy of variance function in heteroscedastic regression models.
    Wang L; Zhou XH
    Biometrics; 2007 Dec; 63(4):1218-25. PubMed ID: 17484775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An accelerated failure time regression model for illness-death data: A frailty approach.
    Kats L; Gorfine M
    Biometrics; 2023 Dec; 79(4):3066-3081. PubMed ID: 37198975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable selection in subdistribution hazard frailty models with competing risks data.
    Ha ID; Lee M; Oh S; Jeong JH; Sylvester R; Lee Y
    Stat Med; 2014 Nov; 33(26):4590-604. PubMed ID: 25042872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.